Page 4,939«..1020..4,9384,9394,9404,941..4,9504,960..»

RPG Research Traumatic Brain Injury Treatment using Role-playing Gaming – Video

Posted: Published on September 2nd, 2013

RPG Research Traumatic Brain Injury Treatment using Role-playing Gaming Research studies on the educational and therapeutic aspects of participation in role-playing games. http://www.rpgresearch.com This video is a presentation o... By: rpgresearch … Continue reading

Posted in Brain Injury Treatment | Comments Off on RPG Research Traumatic Brain Injury Treatment using Role-playing Gaming – Video

Chola MS launches a safety initiative for Govinda revelers

Posted: Published on September 2nd, 2013

In view of rising accidents atDahi Handicelebrations,Cholamandalam MS General Insurance Company Ltd. (Chola MS), the leading provider of insurance products and services, had launched a special safety initiative for Govinda revelers yesterday. As a one of its kind initiative, the company extended backup ambulances and medical support to about 550dahi handiparticipants across 30 locations in Mumbai. As a first response rescue, the ambulances were equipped with doctors and attendants along-with emergency first-aid medical kits and oxygen cylinders. This initiative helped 12 Govindas receive timely treatment from the available doctors on board. The participants were from Trimurty Yuva Mandal and Kalubhai Govinda. This was part of the insurance majors corporate social responsibility (CSR) initiative. The past couple of years have seen a steep rise in casualties during theJanmashtamicelebrations. The height of thedahi handipyramids are eight-tiers and more. A fall from this height can be fatal. It is our endeavor to reduce the risk or at the very least create a safety net in the event of an accident. This is our way of saying that we are there when you need us the most, says Mr.Neeraj Moorjani, Head Marketing, Chola MS. Dahi Handiis a traditional sport held in celebration of the … Continue reading

Posted in MS Treatment | Comments Off on Chola MS launches a safety initiative for Govinda revelers

UCLA Stem Cell Researcher Wins Prestigious McCulloch and Till Award

Posted: Published on September 2nd, 2013

Dr. Hanna Mikkola, member of the UCLA Eli & Edythe Broad Center for Regenerative Medicine & Stem Cell Research and the Jonsson Comprehensive Center and an associate professor of molecular, cell, and developmental biology in the life sciences has been named the 2013 recipient of the McCulloch and Till Award by the Society for Hematology and Stem Cells, also known as the ISEH. Established in 2004 in honor of Ernest McCulloch and James Till, who are known as the fathers of stem cell science, this award recognizes junior scientists in the field of experimental hematology and stem cells. The award is given annually to one scientist who is nominated and selected as an outstanding early career investigator in the field. Professors McCulloch and Till are widely considered to be the first scientists to show that the bone marrow contains stem cells, a finding that gave rise to the field of bone marrow transplantation. The driving force and long-standing desire behind Mikkolas research is to improve leukemia treatment by understanding the origin of hematopoietic or blood-producing stem cells (HSCs). Mikkola feels she can best contribute to that mission by uncovering the biological mechanisms that control the development of HSCs with the … Continue reading

Posted in Stem Cell Research | Comments Off on UCLA Stem Cell Researcher Wins Prestigious McCulloch and Till Award

Digesting milk in Ethiopia: A case of multiple genetic adaptations

Posted: Published on September 2nd, 2013

Public release date: 29-Aug-2013 [ | E-mail | Share ] Contact: Clare Ryan clare.ryan@ucl.ac.uk 44-020-310-83846 University College London A genetic phenomenon that allows for the selection of multiple genetic mutations that all lead to a similar outcome -- for instance the ability to digest milk -- has been characterised for the first time in humans. The phenomenon, known as a 'soft selective sweep', was described in the population of Ethiopia and reveals that individuals from the Eastern African population have adapted to be able to digest milk, but via different mutations in their genetic material. A team of geneticists from UCL, University of Addis Ababa and Roskilde University have shown that five different alleles are found in the Ethiopian population that cause adult lactase production, one of which is newly confirmed. Their study is published in The American Journal of Human Genetics. Professor Dallas Swallow, from the Department of Genetics, Evolution and Environment, senior author of the paper said: "Our genetic make-up determines our ability to digest milk into adulthood. Just over a third of the global population have inherited genes that allow us to make lactase, the enzyme that digests milk, as adults. "This study shows that several different … Continue reading

Comments Off on Digesting milk in Ethiopia: A case of multiple genetic adaptations

Stem cells may do best with a little help from their friends

Posted: Published on September 2nd, 2013

Aug. 27, 2013 Like volunteers handing out cups of energy drinks to marathon runners, specially engineered "helper cells" transplanted along with stem cells can dole out growth factors to increase the stem cells' endurance, at least briefly, Johns Hopkins researchers report. Their study, published in the September issue of Experimental Neurology, is believed to be the first to test the helper-cell tactic, which they hope will someday help to overcome a major barrier to successful stem cell transplants. "One of the bottlenecks with stem cell therapy is the survival of cells once they're put in the body -- about 80 to 90 percent of them often appear to die," says Jeff Bulte, Ph.D., a professor in the Johns Hopkins University School of Medicine's Institute for Cell Engineering. "We discovered it helps to put the stem cells in with some buddies that give off growth factors." Stem cells can morph to take on any role in the body, making them theoretically useful to treat conditions ranging from type 1 diabetes (replacing insulin-producing cells in the pancreas) to heart disease (taking over for damaged heart cells). The biggest problem for transplanted stem cells, Bulte says, is that they're initially grown in a … Continue reading

Comments Off on Stem cells may do best with a little help from their friends

Retinitis pigmentosa treated with acupuncture – Video

Posted: Published on September 1st, 2013

Retinitis pigmentosa treated with acupuncture A patient with retinitis pigmentosa describes his treatment with acupuncture by David Russell, LAc, at Russell Family Acupuncture. http://www.acuherbal.com. By: graingerrussell … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Retinitis pigmentosa treated with acupuncture – Video

Second Sight Medical Named 2014 Technology Pioneer

Posted: Published on September 1st, 2013

World Economic Forum Recognizes Creator of Argus II Retinal Prosthesis System with Prestigious Award SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, today announced that the company has been selected as a 2014 Technology Pioneer by the World Economic Forum. At Second Sight, this recognition by the World Economic Forum has validated our commitment to providing state-of-the-art technology to patients suffering from retinitis pigmentosa and other forms of vision loss. Technology Pioneers are a part of the World Economic Forums community of pioneers, disruptors and innovators. Among the criteria for a Technology Pioneer are visionary leadership and the potential to transform the future of business and society. The award follows the launch of the Argus II Retinal Prosthesis System, the worlds first approved device intended to restore some functional vision for people suffering from blindness due to outer retinal degenerations. The Argus II has been approved for market distribution in both Europe and the U.S. We are honored and humbled to be named alongside such prominent, world-class innovators as a 2014 Technology Pioneer, said Robert Greenberg, MD PhD, President and Chief Executive Officer at Second Sight. At Second Sight, this recognition by … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Second Sight Medical Named 2014 Technology Pioneer

Three months after risky stem cell transplant, young patient shows no signs of sickle cell

Posted: Published on September 1st, 2013

After spending three months undergoing and recovering from a risky stem cell transplant, 10-year-old Caitlyn Hill left St. Louis Children's Hospital last week without any signs of her sickle cell disease. Caitlyn is only the third person to receive a cord blood transplant to treat sickle cell as part of a nationwide study involving Washington University School of Medicine, where researchers are leading the way in finding easier and safer ways to treat non-cancerous diseases with bone marrow and stem cell transplants. For Caitlyn's parents, who for months lived with the fear their young daughter could suffer a stroke, the idea that she could no longer suffer symptoms from the inherited blood disorder hasn't sunk in -- even after seeing Caitlyn's red blood cell counts at levels they had never seen. "It's hard to see beyond to think, 'Oh my gosh, maybe she'll never have sickle cell in her life. We haven't totally grasped that," said Lena Hill, 38, of Iowa City, Iowa. "We feel really blessed we had Dr. Shenoy to cure our child of the disease." Dr. Shalini Shenoy is the director of the hospital's Pediatric Stem Cell Transplant Program and a pioneer in developing the protocol for … Continue reading

Posted in Stem Cell Transplant | Comments Off on Three months after risky stem cell transplant, young patient shows no signs of sickle cell

Girl, 10, shows no sign of sickle cell after stem cell transplant in St. Louis

Posted: Published on September 1st, 2013

After spending three months undergoing and recovering from a risky stem cell transplant, 10-year-old Caitlyn Hill left St. Louis Childrens Hospital last week without any signs of her sickle cell disease. Caitlyn is only the third person to receive a cord blood transplant from an unrelated donor to treat sickle cell as part of a nationwide study involving Washington University School of Medicine, where researchers are leading the way in finding easier and safer ways to treat non-cancerous diseases with bone marrow and stem cell transplants. For Caitlyns parents, who for months lived with the fear their young daughter could suffer a stroke, the idea that she could no longer suffer symptoms from the inherited blood disorder hasnt sunk in even after seeing Caitlyns red blood cell counts at levels they had never seen. Its hard to see beyond to think, Oh my gosh, maybe shell never have sickle cell in her life. We havent totally grasped that, said Lena Hill, 38, of Iowa City, Iowa. We feel really blessed we had Dr. Shenoy to cure our child of the disease. Dr. Shalini Shenoy is the director of the hospitals Pediatric Stem Cell Transplant Program and a pioneer in developing … Continue reading

Posted in Stem Cell Transplant | Comments Off on Girl, 10, shows no sign of sickle cell after stem cell transplant in St. Louis

Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India – Video

Posted: Published on September 1st, 2013

Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India Improvement seen in just 6 months after Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Earli... By: Neurogen Brain and Spine Institute … Continue reading

Comments Off on Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India – Video

Page 4,939«..1020..4,9384,9394,9404,941..4,9504,960..»